Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tesaro Inc (TSRO)

Tesaro Inc (TSRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tesaro Inc 1000 WINTER STREET WALTHAM MA 02451 USA

www.tesarobio.com P: 339-970-0900

Description:

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 4,126,323
Shares Outstanding, K 55,047
Annual Sales, $ 223,330 K
Annual Net Income, $ -496,130 K
Last Quarter Sales, $ 64,400 K
Last Quarter Net Income, $ -137,090 K
60-Month Beta 0.38
% of Insider Shareholders 33.70%

Growth:

1-Year Return 18.05%
3-Year Return 93.70%
5-Year Return 113.32%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -133.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.49 on 11/01/18
Next Earnings Date 02/26/19
Earnings Per Share ttm -11.86
EPS Growth vs. Prev Qtr 18.09%
EPS Growth vs. Prev Year -429.79%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TSRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,209.72%
Return-on-Assets % -83.34%
Profit Margin % -222.15%
Debt/Equity N/A
Price/Sales 18.81
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.38
Interest Coverage -24.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar